243 related articles for article (PubMed ID: 25679268)
1. A binding mode hypothesis of tiagabine confirms liothyronine effect on γ-aminobutyric acid transporter 1 (GAT1).
Jurik A; Zdrazil B; Holy M; Stockner T; Sitte HH; Ecker GF
J Med Chem; 2015 Mar; 58(5):2149-58. PubMed ID: 25679268
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of GABA reuptake inhibition.
Motiwala Z; Aduri NG; Shaye H; Han GW; Lam JH; Katritch V; Cherezov V; Gati C
Nature; 2022 Jun; 606(7915):820-826. PubMed ID: 35676483
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for substrate recognition and transport of human GABA transporter GAT1.
Zhu A; Huang J; Kong F; Tan J; Lei J; Yuan Y; Yan C
Nat Struct Mol Biol; 2023 Jul; 30(7):1012-1022. PubMed ID: 37400655
[TBL] [Abstract][Full Text] [Related]
4. Different Binding Modes of Small and Large Binders of GAT1.
Wein T; Petrera M; Allmendinger L; Höfner G; Pabel J; Wanner KT
ChemMedChem; 2016 Mar; 11(5):509-18. PubMed ID: 26804464
[TBL] [Abstract][Full Text] [Related]
5. Development of Highly Potent GAT1 Inhibitors: Synthesis of Nipecotic Acid Derivatives with N-Arylalkynyl Substituents.
Lutz T; Wein T; Höfner G; Wanner KT
ChemMedChem; 2017 Mar; 12(5):362-371. PubMed ID: 28125164
[TBL] [Abstract][Full Text] [Related]
6. Structure activity relationship of selective GABA uptake inhibitors.
Vogensen SB; Jørgensen L; Madsen KK; Jurik A; Borkar N; Rosatelli E; Nielsen B; Ecker GF; Schousboe A; Clausen RP
Bioorg Med Chem; 2015 May; 23(10):2480-8. PubMed ID: 25882526
[TBL] [Abstract][Full Text] [Related]
7. A possible role of the non-GAT1 GABA transporters in transfer of GABA from GABAergic to glutamatergic neurons in mouse cerebellar neuronal cultures.
Suñol C; Babot Z; Cristòfol R; Sonnewald U; Waagepetersen HS; Schousboe A
Neurochem Res; 2010 Sep; 35(9):1384-90. PubMed ID: 20512624
[TBL] [Abstract][Full Text] [Related]
8. GABA transporters as drug targets for modulation of GABAergic activity.
Schousboe A; Sarup A; Larsson OM; White HS
Biochem Pharmacol; 2004 Oct; 68(8):1557-63. PubMed ID: 15451399
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship and pharmacology of gamma-aminobutyric acid (GABA) transport inhibitors.
Clausen RP; Madsen K; Larsson OM; Frølund B; Krogsgaard-Larsen P; Schousboe A
Adv Pharmacol; 2006; 54():265-84. PubMed ID: 17175818
[No Abstract] [Full Text] [Related]
10. Potential role of selected antiepileptics used in neuropathic pain as human GABA transporter isoform 1 (GAT1) inhibitors-Molecular docking and pharmacodynamic studies.
Fijałkowski Ł; Sałat K; Podkowa A; Zaręba P; Nowaczyk A
Eur J Pharm Sci; 2017 Jan; 96():362-372. PubMed ID: 27721044
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of N-substituted nipecotic acid derivatives with an unsymmetrical bis-aromatic residue attached to a vinyl ether spacer as potential GABA uptake inhibitors.
Quandt G; Höfner G; Wanner KT
Bioorg Med Chem; 2013 Jun; 21(11):3363-78. PubMed ID: 23598250
[TBL] [Abstract][Full Text] [Related]
12. [11C]flumazenil binding is increased in a dose-dependent manner with tiagabine-induced elevations in GABA levels.
Frankle WG; Cho RY; Mason NS; Chen CM; Himes M; Walker C; Lewis DA; Mathis CA; Narendran R
PLoS One; 2012; 7(2):e32443. PubMed ID: 22384252
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with an alkyne spacer as GABA uptake inhibitors.
Tóth K; Höfner G; Wanner KT
Bioorg Med Chem; 2018 Jul; 26(12):3668-3687. PubMed ID: 29886082
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of uptake, steady-state currents, and transient charge movements generated by the neuronal GABA transporter by various anticonvulsant drugs.
Eckstein-Ludwig U; Fei J; Schwarz W
Br J Pharmacol; 1999 Sep; 128(1):92-102. PubMed ID: 10498839
[TBL] [Abstract][Full Text] [Related]
15. An historical perspective on GABAergic drugs.
Froestl W
Future Med Chem; 2011 Feb; 3(2):163-75. PubMed ID: 21428811
[TBL] [Abstract][Full Text] [Related]
16. Involvement of sialic acid in the regulation of γ--aminobutyric acid uptake activity of γ-aminobutyric acid transporter 1.
Hu J; Fei J; Reutter W; Fan H
Glycobiology; 2011 Mar; 21(3):329-39. PubMed ID: 21045010
[TBL] [Abstract][Full Text] [Related]
17. GABA transport goes structural.
Kanner BI; Dayan-Alon O
Trends Pharmacol Sci; 2023 Jan; 44(1):4-6. PubMed ID: 35985875
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, Evaluation and Computational Studies of Nipecotic Acid-Acetonaphthone Hybrids as Potential Antiepileptic Agents.
Seth A; Sharma PA; Tripathi A; Choubey PK; Srivastava P; Tripathi PN; Shrivastava SK
Med Chem; 2018; 14(4):409-426. PubMed ID: 29336266
[TBL] [Abstract][Full Text] [Related]
19. Synaptic and extrasynaptic GABA transporters as targets for anti-epileptic drugs.
Madsen KK; Clausen RP; Larsson OM; Krogsgaard-Larsen P; Schousboe A; White HS
J Neurochem; 2009 May; 109 Suppl 1():139-44. PubMed ID: 19393020
[TBL] [Abstract][Full Text] [Related]
20. Structural insights into GABA transport inhibition using an engineered neurotransmitter transporter.
Joseph D; Nayak SR; Penmatsa A
EMBO J; 2022 Aug; 41(15):e110735. PubMed ID: 35796008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
